Dean Koh

Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population.

Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement.

Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%.

Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.

Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.

The company announced last week that it had placed its One-minute Clinics across 8 provinces and cities in China and signed service contracts for nearly 1,000 units.

Yesterday, Shanghai-based insurtech startup CareVoice (who launched their AI voice-based virtual health assistant for insurers and employers in Greater China in May 2018) announced the official launch of StartupCare, the first health benefit and insurance for startups in China.

The digital managed care platform MyDoc has been tapped to digitally deliver health screening results of AIA Vitality members in Singapore, creating the first digitally integrated corporate health screening programme for the global insurer.

The Singapore headquartered mClinica has recently reached a milestone to become the largest pharmacy data technology player in Southeast Asia: its platform is now being used by 1 in every 2 pharmacists in the Philippines, 1 in every 3 pharmacists in Indonesia and 1 in every 4 pharmacists in Vietnam.

Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding.